Core Viewpoint - GE HealthCare Technologies (GEHC) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][4]. Earnings Estimates and Stock Ratings - The Zacks rating system focuses on changes in earnings estimates, which are crucial for assessing a company's future earnings potential and stock price movements [2][5]. - The Zacks Consensus Estimate for GE HealthCare has increased by 12.7% over the past three months, reflecting analysts' growing confidence in the company's earnings outlook [9]. Impact of Institutional Investors - Changes in earnings estimates are closely correlated with stock price movements, largely due to institutional investors who adjust their valuations based on these estimates [5][6]. - An increase in earnings estimates typically leads to higher fair value calculations for stocks, prompting institutional buying that drives stock prices up [5]. Zacks Rank System - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - GE HealthCare's upgrade to Zacks Rank 1 places it in the top 5% of stocks covered by Zacks, suggesting strong potential for market-beating returns in the near term [10][11].

Core Viewpoint - American Lithium Corp. (AMLIF) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is based solely on a company's changing earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade for American Lithium reflects an improvement in the company's earnings outlook, which is expected to positively impact its stock price [4][6]. Impact of Earnings Estimate Revisions - There is a strong correlation between changes in earnings estimates and near-term stock price movements, with institutional investors using these estimates to determine fair value [5][7]. - For American Lithium, a 75% increase in the Zacks Consensus Estimate over the past three months indicates a positive trend in earnings estimates [9]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [8]. - American Lithium's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10][11].

Core Viewpoint - Moleculin Biotech, Inc. (MBRX) has been upgraded to a Zacks Rank 2 (Buy), indicating an upward trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to institutional investors adjusting their valuations, resulting in stock price movements due to large transactions [4]. Company Performance and Outlook - The upgrade for Moleculin Biotech suggests an improvement in the company's underlying business, which could lead to higher stock prices as investors respond positively [5]. - Over the past three months, the Zacks Consensus Estimate for Moleculin Biotech has increased by 47.2%, indicating a positive trend in earnings expectations [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with only the top 20% receiving a "Strong Buy" or "Buy" rating, indicating superior earnings estimate revisions [9][10]. - The upgrade of Moleculin Biotech to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Core Viewpoint - Local Bounti Corporation (LOCL) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are crucial for predicting near-term stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4][5]. Recent Developments for Local Bounti - Local Bounti is projected to earn -$7.68 per share for the fiscal year ending December 2025, with no year-over-year change expected [8]. - Over the past three months, the Zacks Consensus Estimate for Local Bounti has increased by 13.7%, reflecting a positive trend in earnings estimates [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - The upgrade of Local Bounti to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10].

Core Viewpoint - Jackson Financial (JXN) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are crucial for predicting near-term stock price movements [2][4]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in buying or selling pressure that affects stock prices [4]. Company-Specific Insights - The upgrade for Jackson Financial reflects an improvement in its underlying business, suggesting that investor sentiment may drive the stock price higher [5]. - Jackson Financial is projected to earn $20.44 per share for the fiscal year ending December 2025, with no year-over-year change, but the Zacks Consensus Estimate has increased by 5.9% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [7]. - The upgrade to Zacks Rank 2 places Jackson Financial in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Kezar Life Sciences, Inc. (KZR) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system tracks the Zacks Consensus Estimate, which reflects EPS estimates from sell-side analysts for the current and following years, highlighting the importance of earnings revisions in stock valuation [1][4]. - A strong correlation exists between changes in earnings estimates and near-term stock price movements, primarily due to institutional investors adjusting their valuations based on these estimates [4][6]. Recent Developments for Kezar Life Sciences - For the fiscal year ending December 2025, Kezar Life Sciences is expected to earn -$7.22 per share, which remains unchanged from the previous year, but analysts have raised their estimates by 3.4% over the past three months [8]. - The upgrade to Zacks Rank 2 places Kezar Life Sciences in the top 20% of Zacks-covered stocks, suggesting potential for higher stock prices in the near term [10]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7][9]. - The system maintains a balanced distribution of "buy" and "sell" ratings, ensuring that only the top 5% of stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [9][10].

Core Viewpoint - Sprouts Farmers Market (SFM) has experienced a significant downtrend, with a 14.8% decline in stock price over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to improved earnings expectations from analysts [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 indicating that a stock may be oversold [2]. - SFM's current RSI reading is 23.43, indicating that the heavy selling pressure may be exhausting, which could lead to a price rebound as the stock seeks to return to its previous equilibrium [5]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts regarding SFM's earnings estimates, with a 0% increase in the consensus EPS estimate over the last 30 days, suggesting that upward revisions in earnings estimates typically lead to price appreciation [7]. - SFM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises, indicating a strong potential for a near-term turnaround [8].

Manchester United (MANU) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +55.56%. A quarter ago, it was expected that this soccer club would post a loss of $0.33 per share when it actually produced a loss of $0.04, delivering a surprise of +87.88%.Over the last four quarters, the company has ...

Core Viewpoint - Chord Energy Corporation's stock experienced a significant increase of 4% to close at $106.42, driven by a strong trading volume and positive investor sentiment following the announcement of a $750 million senior notes offering to fund an acquisition in North Dakota's Williston Basin [1][2]. Group 1: Company Performance - Chord Energy's shares rose after the company announced an increase in its senior notes offering to $750 million, aimed at acquiring valuable oil and gas assets from XTO Energy, a subsidiary of ExxonMobil [2]. - The company is expected to report quarterly earnings of $2.07 per share, reflecting a year-over-year decline of 39.1%, with revenues projected at $1.33 billion, down 8.2% from the previous year [3]. - The consensus EPS estimate for Chord Energy has been revised slightly higher over the last 30 days, indicating a positive trend that may lead to price appreciation [4]. Group 2: Market Reaction and Analyst Insights - Investors reacted positively to Chord Energy's acquisition strategy, viewing it as a smart move that enhances future earnings potential while maintaining a conservative balance sheet [2]. - Analysts have raised price targets for Chord Energy, suggesting expectations that the acquisition will improve the company's scale and shareholder value [2]. - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook in the market [5].

Company Performance - Flux Power Holdings, Inc. (FLUX) reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.1, and improved from a loss of $0.17 per share a year ago, resulting in an earnings surprise of +100.00% [1] - The company posted revenues of $16.74 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 0.77%, and showing an increase from year-ago revenues of $13.23 million [2] - Over the last four quarters, Flux Power has surpassed consensus revenue estimates three times [2] Stock Movement and Outlook - Flux Power shares have increased approximately 31% since the beginning of the year, outperforming the S&P 500's gain of 12.5% [3] - The sustainability of the stock's immediate price movement will depend on management's commentary during the earnings call [3][4] - The current consensus EPS estimate for the upcoming quarter is -$0.05 on $18 million in revenues, and for the current fiscal year, it is -$0.05 on $76.76 million in revenues [7] Industry Context - The Electronics - Miscellaneous Products industry, to which Flux Power belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Flux Power's stock performance [5][6]